QTTB

Q32 BIO INC

QTTB·746964105·US·Common Stock·Healthcare - Biotechnology-Activist

QTTB (Q32 BIO INC) is held by 33 institutional investors as of Q1 2026. Largest holders: Carlyle Group Inc. ($7.1M), VANGUARD CAPITAL MANAGEMENT LLC ($2M), MACKENZIE FINANCIAL CORP ($1.6M). Net institutional sentiment: Mixed.

33
Holders
(4 Elite)
$15.5M
Total Value
61% (28)
Consensus
17 buying - 11 selling
13F: Insider & Congress:
QTTB

Smart Money Verdict

View all
Held by 33 funds
4 elite

Who's Trading

ActivistBOBoxer Capital Management, LLC13.3%Jul 10, 2026
ActivistThe Carlyle Group Inc.The Carlyle Group Inc.4.1%Jul 6, 2026
ActivistBLBVF PARTNERS L P/IL10.0%Jun 4, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.9.8%Jun 4, 2026
ActivistOAORBIMED ADVISORS LLC17.4%Jun 1, 2026
ActivistAVAtlas Venture Fund X, L.P.3.6%May 28, 2026
InsiderMPMorrison Jodie PopeSell $45KFeb 25, 2026
InsiderVMViolette Shelia M.Sell $13KFeb 25, 2026
InsiderKLKalowski LeeSell $18KFeb 25, 2026
InsiderMPMorrison Jodie PopeSell $19KAug 26, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
1.1M$7.1M0.1%-34.21%
0
New
306,401$2M0.0%+129.24%
40
New
246,304$1.6M0.0%+129.24%
35
Increased
206,915(+107.8%)$1.3M0.0%+204.91%
41
Increased
118,152(+11.3%)$758,7400.0%-13.32%
19
Increased
86,147(+43.7%)$553,0630.0%+206.98%
22
Increased
65,599(+158.5%)$421,1450.0%+164.62%
39
New
52,440$336,6640.0%+129.24%
33
New
49,995$320,9680.0%+129.24%
33
Decreased
42,346(-9.6%)$271,8610.0%+376.58%
0
Increased
41,514(+95.5%)$266,5200.0%-13.50%
25
Unchanged
25,033$160,7120.0%-70.40%
0
New
20,695$132,8620.0%+129.24%
31
New
18,770$120,5030.0%+129.24%
30
Decreased
15,481(-66.2%)$99,3880.0%+283.75%
0
Increased
9,560(+74.5%)$61,3750.0%+63.09%
21
Increased
3,400(+1.1%)$21,8280.0%+295.34%
13
Increased
2,744(+1067.7%)$18,0000.0%+142.24%
20
Unchanged
2,273$14,5930.0%+192.38%
0
New
1,915$12,2940.0%+129.24%
27

Showing 1-20 of 39

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used